#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Brendan O'Leary Email
Chief Financial Officer / Chief Operating Officer . Xalud Therapeutics
New York , NY
LocationPrimary Email
How to contact Brendan O'Leary
Join and see Brendan's contact info for free!Phone
Current Roles
Employees:
43Revenue:
$6.7MAbout
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.Xalud Therapeutics Address
40 West 57th StreetNew York , NY
United States